PainReform Ltd
NASDAQ:PRFX
PainReform Ltd
NASDAQ:PRFX
Price:
2.22
USD
0.91%
Market Cap:
$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PainReform Ltd
NASDAQ:PRFX
|
IL |
|
US Masters Residential Property Fund
ASX:URF
|
AU |
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
Kerala Ayurveda Ltd
BSE:530163
|
IN |
|
M
|
Maagh Advertising & Marketing Services Ltd
BSE:543624
|
IN |
|
TVS Electronics Ltd
NSE:TVSELECT
|
IN |
|
T
|
Tatneft' PAO
MOEX:TATNP
|
RU |
|
Shun Tak Holdings Ltd
HKEX:242
|
HK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PRFX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PRFX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
PRFX Competitors Multiples
PainReform Ltd Competitors
PainReform Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
PainReform Ltd
NASDAQ:PRFX
|
1.7m USD | 0 | -0.1 | 0.1 | 0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.2 | 21.6 | 15 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
